Table 7.

MDS/ANLL After High-Dose Treatment With Autografting for HD and NHL

Institution (reference) Patients (no.) MDS/ANLL (no.) Actuarial IncidenceMedian Time From Autografting (yr)
(%) (yr)
Nebraska125 511  12  8-10  3 3.7  
Dana-Farber126 262  20  18  6 2.6  
Minnesota127 206  9  14.5  5 2.8  
City of Hope128 275  10  9  3 1.4 
Institution (reference) Patients (no.) MDS/ANLL (no.) Actuarial IncidenceMedian Time From Autografting (yr)
(%) (yr)
Nebraska125 511  12  8-10  3 3.7  
Dana-Farber126 262  20  18  6 2.6  
Minnesota127 206  9  14.5  5 2.8  
City of Hope128 275  10  9  3 1.4 
View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal